STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 251 participants.
Also called NCT03777631
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 251 participants
- Registry
-
NCT03777631
-
- Other papers using this trial's data
- Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT03777631. Randomized; no masking; primary purpose prevention. Start 2018-04-01 (actual); primary completion 2026-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
- Acronym
- STABLED
- Condition
- Ischemic Stroke
- Condition
- Atrial Fibrillation Non-Rheumatic
- Intervention (Procedure)
- Catheter ablation
- Lead sponsor
- Nippon Medical School
- Collaborator
- Daiichi Sankyo Co., Ltd.
Record details
- Record id
cardio:ct-nct03777631- Content hash
187097141d63743d1f259a1bf056eea0de39616564665fa4acd02edf19f60eb0